common side effects of compounded semaglutide Effects: What Patients Should Know in 2025 Semaglutide Patient Safety Updates |

Weight loss is not just about willpowerits about finding the right medical support tailored to your body

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide (Wegovy), are increasingly used for weight management in both adult and pediatric populations

Integration of obesity medicine into gastroenterology training programs and metabolic clinics may further redefine the future scope of GI practice.Modern gastroenterology is undergoing a transition toward obesity-focused and metabolic care

Clear role: high-efficacy anchor therapy with adherence advantages

Currently, there are no specific drugs available for its treatment

With the rise in use of GLP-1 drugs, health insurers must balance these drugs proven effectiveness with the cost of treatment